InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
3
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Rosenberg Noah L., Directeur Médical. Insider active across 2 companies, notably Travere Therapeutics, Inc.. Cumulatively, 6 filings have been logged. Breakdown: 3 buys · 2 sells. Total volume traded: €56k. Activity tracked since 11 May 2021. The latest transaction was disclosed on 17 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Rosenberg Noah L.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
4,200 shares@ US$4.91Common StockSEC:0001579649-26-000005:0
Canonical exit: 15 Nov 2026 (T+90)
2,030 shares@ US$4.92Common StockSEC:0001579649-26-000005:1
Canonical exit: 16 Nov 2026 (T+90)
2,357 shares@ US$4.2425100.0% of flowCommon StockSEC:0001579649-25-000004:0
Canonical exit: 23 Feb 2026 (T+90)
4,500 shares0Common StockSEC:0001209191-21-052083:0
1,250 shares@ US$13.8171.1% of flowCommon StockSEC:0001209191-21-048494:0
375 shares@ US$19.1428.9% of flowCommon StockSEC:0001209191-21-032319:0
6 of 6 declarations
About Rosenberg Noah L.
Noah L. Rosenberg is the Chief Medical Officer at Travere Therapeutics, Inc. He is responsible for medical strategy and clinical research. His expertise in medicine and drug development is essential for guiding the company's research initiatives.
